Thrombopoietin mimetics for systemic lupus erythematosus with antiphospholipid antibodies should be discussed separately.

Kanda, M; Atsumi, T

Kanda, M; Atsumi, T.

Affiliation

Kanda M; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University.
Atsumi T; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University.

Lupus ; 27(11): 1876-1877, 2018 10.

Article in En | MEDLINE | ID: mdl-29958500

Subject(s)

Antibodies, Antiphospholipid/blood; Benzoates/pharmacology; Hydrazines/pharmacology; Purpura, Thrombocytopenic, Idiopathic/drug therapy; Pyrazoles/pharmacology; Recombinant Fusion Proteins/pharmacology; Thrombopoietin/pharmacology; Antiphospholipid Syndrome/complications; Benzoates/adverse effects; Humans; Hydrazines/adverse effects; Lupus Erythematosus, Systemic/complications; Pyrazoles/adverse effects; Receptors, Fc; Recombinant Fusion Proteins/adverse effects; Thrombopoietin/adverse effects; Venous Thromboembolism/chemically induced

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Thrombopoietin / Benzoates / Recombinant Fusion Proteins / Purpura, Thrombocytopenic, Idiopathic / Antibodies, Antiphospholipid / Hydrazines Limits: Humans Language: En Journal: Lupus Journal subject: REUMATOLOGIA Year: 2018 Type: Article

Fulltext

XML

PubMed Links

Search on Google